TIAFT2006 PROCEEDINGS
The International Association of Forensic Toxicologists
44th International meeting TIAFT 2006
27th Aug – 1st Sept 2006
Ljubljana, Slovenia
 
Organized in
co-operation with
• TIAFT / www.tiaft.org
• FORTOX - Association for Development of Forensic Toxicology and other Forensic Sciences / www.fortox.net
• Institute of Forensic medicine, Medical faculty, University of Ljubljana
• Slovenian Toxicological Association
 
Edited by
Majda Zorec Karlovšek
 
Co-edited by
FORTOX – Association for Development of Forensic Toxicology and other Forensic Sciences
 
Published by
FORTOX – Association for Development of Forensic Toxicology and other Forensic Sciences
 
Designed by
Luka Mancini / lukatarina.net
 
Technical support
• INFOBIA d.o.o. / www.infobia.net
• Birografika BORI d.o.o. / www.birografikabori.si
 
The TIAFT2006 Proceedings contain a total of 200 contributions, among them 18 in the form of full papers presented at the 44th annual meeting of The International Association of Forensic Toxicologists (TIAFT2006) held in Ljubljana from 27 August to 1 September 2006.

Many of papers have been published in peer-reviewed journals: 23 in Forensic Science International, Volume 170, Issue 2/3, pp. 93–216 (6 August 2007) and 3 in the Journal of Chromatography B, Vol. 855, No.2.

The Proceedings also include 14 lectures presented at the symposium Medicinal Drugs and Human Performance

During the meeting, a roundtable on illegal drugs and traffic safety was arranged. The contributions from different countries were organized according to a questionnaire prepared by chairmen Prof. Olaf Drummer and Prof. Jorg Morland. A summary of these reports, assembled by Prof. Drummer, is also part of the TIAFT2006 proceedings.

Some additional contributions highlight the scientific activities and social events during the conference.

As editor of this volume, I would like to thank the authors for their contributions and the members of scientific committee for their support, especially in reviewing manuscripts. It was a great pleasure to work with you.

Majda Zorec Karlovšek
Chair, TIAFT2006




OPENING CEREMONY (OC)
PLENARY LECTURES (PL)
ROUND TABLE: Illegal Drugs and Traffic Safety
ADDITIONAL DOCUMENTS

ANALYTICAL METHODS (AM)
WORKPLACE DRUG TESTING & DOPING CONTROL (WD)
BEHAVIORAL TOXICOLOGY (BT)
ALTERNATIVE SPECIMENS (AS)
POST-MORTEM TOXICOLOGY (PT)
OCCUPATIONAL & ENVIRONMENTAL TOXICOLOGY (OE)
CLINICAL FORENSIC TOXICOLOGY (CT)
DRUGS OF ABUSE (DA)
TOXINS & HERBALS & VENOMS (TH)
SYMPOSIUM: Medicinal Drugs and Human Performance

TIAFT 2006 Abstract Book (complete)



OPENING CEREMONY
OC-01 Opening address I
Majda Zorec Karlovšek
TIAFT2006 Chairperson
• Full Text

OC-02 Opening address II
Dr. Pascal Kintz
TIAFT President
• Full Text

OC-03 Opening address III
Prof. Boštjan Žeks
President of Slovenian Academy of Sciences and Arts
• Full Text - english
• Full Text - slovene

Top
PLENARY LECTURES
PL-01 Scopolia Carniolica, J.A.Scopoli, Scopolamine
M.Zorec Karlovšek, D.Soban, A.Krbavčič, A.Kobal, Z.Zupanič-Slavec
Medical Faculty, Ljubljana, Slovenia
• Abstract
• Full Text
• Presentation

PL-02 Scopolamine – its role in clinical and forensic toxicology
Hans H. Maurer
Department of Experimental and Clinical Toxicology, Saarland University, D-66421 Homburg (Saar)
• Abstract


PL-03 Orfila and Stas: the fathers of modern toxicology
Robert Wennig
Laboratoire national de santé, Luxembourg
• Abstract


PL-04 Advancements in technology for the confirmation of drugs in oral fluid and hair
Christine Moore
Immunalysis Corporation, Vice President, Toxicology Research and Development, Pomona, CA, USA
• Abstract


Top
ROUND TABLE: Illegal Drugs and Traffic Safety
  • Questionnaire.pdf
• DUID Summary.xls

Top
ADDITIONAL DOCUMENTS
  • Slovenian Anthem
• Fritz Pregl
• Professor Machata: letter
• TIAFT2006: awards and recognitions

Top
ANALYTICAL METHODS
Platform Presentations
-
Poster Presentations
AM-o-01 Forensic strategy for the detection of plant toxin ricin
Yasuo Seto, Mieko Kanamori-Kataoka, Isaac Ohsawa, Kouichiro Tsuge, Takeshi Ohmori, Yasuo Takayama, Yasuo Takayama and Ryoji Sekiokas
National Research Institute of Police Science, Kashiwa, Japan, Chiba
• Abstract
• Full Text

AM-o-02 The use of certified reference materials in forensic toxicology
Christian Zeine
LGC Promochem GmbH, PFC, Wesel, Germany
• Abstract


AM-o-03 An LC/MS-APCI method for screening and quantification of four fentanyl analogues, atropine and scopolamine in biosamples
Agnieszka Skulska1,2 and Maria Kala2
1J. Beyer Faculty of Chemistry, Jagiellonian University, Cracow, Poland; 2 Institute of Forensic Research, Cracow, Poland
• Abstract


AM-o-04 Detection and validated quantification of the herbal phenalkylamines and methcatinone in human blood plasma by LC-MS-MS
J. Beyer1, F.T. Peters1, T. Kraemer2, and H.H. Maurer1
1Department of Experimental and Clinical Toxicology; 2Institute of Legal Medicine, Saarland University, Homburg (Saar), Germany
• Abstract


AM-o-05 Quantification of basic lipophilic drugs in blood without reference standards by LC-CLND based on extraction recovery estimation
Suvi Ojanperä, Soile Tuominen, Ilkka Ojanperä
Department of Forensic Medicine, University of Helsinki, Finnland
• Abstract


AM-o-06 The validation and use of an accredited routine method for the simultaneous analysis of cocaine and two breakdown products in oral fluid by LC-MS-MS
Peter Akrill, Claire Reid, Lisa Wilson, Amy Reed, Gail Cooper and Chris Hand
Cozart Bioscience Ltd., Abingdon, Oxfordshire, UK
• Abstract
• Full Text


AM-o-07 Microwave assisted acid hydrolysis of urine as a variation of GC-MS based Systematic Toxicological Analysis (STA)
L.D. Paul and R.F. Staack
Institute of Forensic Medicine, University of Munich, Germany
• Abstract


AM-o-08 An automated SPE procedure for the simultaneous extraction of the majority of medicinal drugs that affect the mind
Diana Kappatos, Stuart Dickson, Sarah Kenworthy, Richard Berezowski, Julie Midgley and Sima Mala
Institute of Environmental Science & Research Limited (ESR), New Zealand
• Abstract


AM-o-09 Determination of Cannabis compounds in blood samples by headspace solid-phase microextraction and gas chromatography-mass spectrometry
C.Jurado and M.P.Gimenez
Instituto Nacional de Toxicología y Ciencias Forenses, Sevilla,Spain
• Abstract


AM-o-10 On-line extraction of benzodiazepines using restricted access media and monolithic silica support with a column-switching approach for LC-MS analysis
A. Bugey and C. Staub
Institute of Forensic Medicine, University of Geneva, Geneva, Switzerland
• Abstract


AM-o-11 Molecularly imprinted polymer for solid-phase extraction of diazepam and its metabolites from hair samples
Marinah M. Ariffin1, Eleanor. I. Miller1, Peter A. G. Cormack2 and Robert A. Anderson1
1University of Glasgow, UK; 2University of Strathclyde, UK
• Abstract


AM-o-12 An improved method for cyanide determination in blood using solid-phase microextraction and gas chromatography/mass spectrometry
Giampietro Frison, Flavio Zancanaro, Donata Favretto and Santo Davide Ferrara
Forensic Toxicology and Antidoping, University Hospital of Padova, Padova, Italy
• Abstract


AM-o-13 LC-ESI-MS-MS determination of ethyl glucuronide and ethyl sulfate in serum
Luca Morini, Lucia Politi, Alessandra Zucchella and Aldo Polettini
Department of Legal Medicine & Public Health, University of Pavia, Pavia, Italy
• Abstract


AM-o-14 Unreliable results can always occur unexpectedly, even if an extensive validated method on LC/MS/MS is used
Donald R.A.Uges, Jan-Pieter Thie and Ben Greijdanus
Laboratory for Clinical and Forensic Drug Monitoring and Toxicology, University Medical Center Groningen, The Netherlands
• Abstract


AM-o-15 Direct detection of methamphetamine and MDMA in human urine by APCI-Ion Trap Mass Spectrometry
Naohito Uetake1, Noriyuki Tachi1, Hiroyuki Inoue2, Yuko T. Iwata2, Tatsuyuki Kanamori2, Hajime Miyaguchi2, Kenji Tsujikawa2, Kenji Kuwayama2 and Tohru Kishi2
1Hitachi Ltd., 2National Research Institute of Police Science, Japan
• Abstract


AM-o-16 Detection of benzodiazepines in hair by ELISA and LC-ESI-MS-MS
Eleanor Isabel Miller, Fiona Mary Wylie and John Samuel Oliver
University of Glasgow, Scotland
• Abstract


AM-o-17 Determination of a designer drug 1-(3-chlorophenyl)piperazine (mCPP) and its parent compound trazodone in hair by High-Performance Liquid Chromatography–Electrospray Mass Spectrometry (HPLC–ESI-MS)
Roman Stanaszek and Wojciech Lechowicz
Institute of Forensic Research, Cracow, Poland
• Abstract


Top
ANALYTICAL METHODS
Poster Presentations
-
Platform Presentations
AM-p-01 Specific screening for illegal drugs and psychoactive medicines in whole blood using LC/MS/MS
Asbjørg S. Christophersen, Unni Johansen and Elisabeth Leere Øiestad
Division of Forensic Toxicology and Drugs Abuse, Norwegian Institute of Public Health P.O. Box 4404 Nydalen, 0443 Oslo Norway
• Abstract


AM-p-02 Analysis of THC, 11-OH-THC, THC-COOH, CBD and CBN by Liquid Chromatography-tandem Mass Spectrometry in human EDTA-plasma and urine after small doses of THC and Cannabis Sativa extract
Sandra Grauwiler1, André Scholer2, Jürgen Drewe3
1University Hospital Basel, Clinical Chemistry Laboratory, Petersgraben 4,CH-4031 Basel; 2Laboratory Medicine, Clinical Chemistry Laboratory, Petersgraben 4, CH-4031 Basel; 3Division of Clinical Pharmacology and Toxicology, University Hospital Basel, CH-4031 Basel
• Abstract


AM-p-03 Detection and analysis of cannabinoids in bio-samples by Surface-Ionization methods
U. Khasanov1, U.Kh.Rasulev1, D.T.Usmanov1, S.S.Iskhakova1, R.K.Akhmedova2
1Arifov Institute of Electronics, Uzbek Academy of Sciences, Akademgorodok, 33 F.Hojaev str., 700125 Tashkent, Uzbekistan; 2Republican Center of Forensic Expertise, Tashkent, Uzbekistan
• Abstract


AM-p-04 Validated method for the determination of ∆9-tetrahydrocannabinol (THC), 11-hydroxy-∆9-THC and 11-nor-9-carboxy-∆9-THC in oral fluid, urine and blood using solid-phase extraction and liquid chromatography- mass spectrometry with electrospray ionization
H.M. Teixeira1,2, A. Verstraete3, P. Proença1, F. Corte-Real1,2, P.V. Monsanto1, D.N. Vieira12
1Medicine, Coimbra, Portugal; 2Faculty of Medicine, Coimbra University, Coimbra, Portugal; 3Laboratory of Clinical Biology-Toxicology, Ghent University Hospital, Ghent, Belgium
• Abstract


AM-p-05 The impurity characteristics of methamphetamine synthesized by Emde and Nagai method
Beom Jun Ko1, SungIll Suh1, Yong Jun Suh1, Moon Kyo In1, Sung-Hong Kim3
1Drug Signature Analysis Center, Supreme Prosecutors’ Office, Seoul 137-730, Korea; 2School of Agricultural Biotechnology, Seoul National University, San 56-1, Sillim-Dong, Gwanak-gu, Seoul, 151-742, Korea; 3Korea Basic Science Institute, Daegu branch, 1370, Sankyuk-Dong, Puk-gu, Daegu, 702-701, Korea
• Abstract


AM-p-06 Determination of ibotenic acid and muscimol in Amanita mushrooms and rat plasma by HPLC-UV and LC/MS
Kenji Tsujikawa1 , Kenji Kuwayama1, Hajime Miyaguchi1, Tatsuyuki Kanamori1, Yuko Iwata1, Hiroyuki Inoue1, Takemi Yoshida2, Tohru Kishi1
1National Research Institute of Police Science, 6-3-1, Kashiwanoha, 277-0882, Kashiwa, Japan, Chiba; 2Department of Biochemical Toxicology, School of Pharmaceutical Sciences, Showa University
• Abstract


AM-p-07 Systematic toxicological analysis of xenobiotics – The LC/MS approach
L. Humbert1, M. Roberts2, M. Wood2, G.Bondoux3, M. Lhermitte1
1Laboratoire de Toxicologie & Génopathies, Hôpital Calmette - CHRU de Lille, 59037 Lille Cedex - France; 2Waters Corporation Atlas Park, Simonsway, Manchester M22 5PP - UK; 3Waters Corporation European Headquarters Waters S.A.S. 78280 Guyancourt - France
• Abstract


AM-p-08 LC-MS/MS determination of urinary 5-hydroxytryptophol glucuronide and 5-hydroxyindole-3-acetic acid
Nikolai Stephanson1, Olof Beck1 and Anders Helander2
1Department of Clinical Pharmacology; 2Department of Clinical Neuroscience, Karolinska Hospital & Institute, Stockholm, Sweden
• Abstract


AM-p-09 Benzodiazepine detection in hair by MISPE v. SPE
Marinah M. Ariffin1, Eleanor I. Miller1, Peter A. G.Cormack2 and Robert A. Anderson1
1University of Glasgow, UK; 1University of Strathclyde, UK
• Abstract


AM-p-10 Screening by immunoassay and confirmation & quantitation by GC-MS of buprenorphine and norbuprenorphine in urine, whole blood and serum
Nina Kangas, Sirpa Mykkänen, Sanna Kyllönen, Päivi Rajala, Kari Ariniemi and Pirjo Lillsunde
Laboratory of Alcohol and Substance Abuse, Department of Mental Health and Alcohol Research, National Public Health Institute, Helsinki, Finland
• Abstract
• Full Text

AM-p-11 Simultaneous determination of newer anti-epileptic drugs (AEDs) by liquid chromatography mass spectrometry (LC-MS)
Chyh Yeng Tan, Eugene Wee Sing Goh, Hsiao Tung Leong, Dr Yi Ju Yao and Dr Danny Siaw Teck Lo
Toxicology Laboratory, Center for Forensic Science, Health Sciences Authority, 11 Outram Road, Singapore
• Abstract


AM-p-12 Screening of basic drugs in urine by GC-NPD, GC-MS and HPLC-DAD: automation and comparison of solid phase extraction columns
Helene B. Klinke, Suzanne Nielsen
Dept. of Forensic Chemistry, Institute of Forensic Medicine, University of Copenhagen, Denmark
• Abstract


AM-p-13 CZE-ESI-TOF MS applied to hair analysis in the screening for drugs of abuse
Rossella Gottardo, Ameriga Fanigliulo, Jennifer P. Pascali, Franco Tagliaro
Department of Medicine and Public Health, Unit of Forensic Medicine, University of Verona, Verona, Italy
• Abstract


AM-p-14 New automated technique for the simultaneous detection of some addictive drugs in saliva samples with the Fast GC/MS SPME Multifiber System
Gagliano-Candela R.1, Strisciullo G.1, Dugheri S.2, Pacenti M.2, Degli Esposti F.3, Arcangeli G.2, Cupelli V.2
1Forensic Toxicology Chair, Department of Internal Medicine and Public Health,University of Bari, P.za G Cesare, 11-70124 Bari, Italy; 2Occupational Medicine Division, Department of Public Health, University of Florence, Largo Palagi, 1- 50134 Florence, Italy; 3ChromLine Srl, Via Anita Garibaldi, 40 -59100 Prato, Italy
• Abstract


AM-p-15 Determination of gamma-hydroxybutyric acid (GHB) and its precursors in blood and urine samples: salting- out approach
A. Kankaanpää, R. Liukkonen and K. Ariniemi
Drug Research Unit, Department of Mental Health and Alcohol Research, National Public Health Institute, Mannerheimintie 166, FIN-00300 Helsinki, Finland
• Abstract


AM-p-16 Detection, confirmation, and quantitation of several drugs of abuse in urine using LC/MS/MS
Tania A. Sasaki1, Robert Galvin2, Daniel Blake2, Bénédicte Duretz3
1Applied Biosystems Foster City, CA USA; 2Applied Biosystems, Warrington, England; 3Applied Biosystems, Les Ulis, France
• Abstract


AM-p-17 Method validation for the simultaneous analysis of organophosphate pesticides in blood by GC/MS
Mee Jung Park, Sang Ki Lee, Ja Youl Yang, Ki Wook Kim, Sang Whan In, You Sin Park, Hee Sun Chung, Young Chan Yoo
National Institute of Scientific Investigation, Seoul 158-707, Korea
• Abstract


AM-p-18 Fast and efficient measurement of the short term alcohol marker 5-hydroxytryptophol / 5-hydroxyindolic acid in urine with RP-HPLC and fluorescence detection
Lydia Halwachs, Rainer W. Schmid
Medical & Chemical Labdiagnostics, University Hospital Vienna, Medical University of Vienna, Austria
• Abstract


AM-p-19 Method validation of cyanide quantification in blood
Ki Wook Kim, Sang Ki Lee, Ja Youl Yang, Mee Jung Park, Sang Whan In, You Sin Park, Hee Sun Chung, Young Chan Yoo
National Institute of Scientific Investigation, Seoul 158-707, Korea
• Abstract


AM-p-20 Simultaneous extraction of alkaline addictive drugs from post-mortem human adipose tissues and GC/MS detection
Perkins de Piacentino A.M.1, Gagliano-Candela R.2, Aventaggiato L.2, Colucci A.P2
1Laboratorio de Toxicologia y Quimica Legal, Cuerpo Medico Forense, Corte Suprema de Justicia de la Nacion, Viamonte 2151, C1056ABG Buenos Aires, Argentina; 2Forensic Toxicology Chair, Department of Internal Medicine and Public Health, University of Bari, P.za G. Cesare 11 – 70124 Bari, Italy
• Abstract


AM-p-21 A high-throughput on-line SPE-LC-MS/MS method for the analysis of 14 antidepressants and metabolites in plasma
A. de Castro2, M.M. Ramírez1, M.Laloup1, N. Samyn1, G. De Boeck1, M. López-Rivadulla2
1Toxicology Section. National Institute of Criminalistics and Criminology, Brussels, Belgium; 2Forensic Toxicology Service, Institute of Legal Medicine, University of Santiago of Compostela, Spain
• Abstract


AM-p-22 Glass catalysed conversion of candesartan cilexetil to the active metabolite candesartan and its alkylated derivates
Nerea Ferreirós, Sebastian Dresen, Volker Auwaerter, Wolfgang Weinmann
Institute of Forensic Medicine, University Hospital Freiburg, Albertstr. 9, D 79104 Freiburg, Germany
• Abstract


AM-p-23 Analysis of urine organic acids using Linear Retention Indices for the determination of inherited metabolic disorders
Margit Geissler1, Shuichi Kawana2
1Shimadzu Europa GmbH, Duisburg, Germany; 2Shimadzu Corporation, Kyoto, Japan
• Abstract


AM-p-24 Development of a Multiplex Toxicology Panel of Immunoassays
William Link, Renato del Rosario, Joel Hardy, David King, Raisa Lerner, Randy Sweet, and Kunquan Yao
Bio-Rad Laboratories Inc, Hercules, CA 94547, USA
• Abstract


AM-p-25 Identification of anabolic agent abuse in sport: determination of androgen glucuro- and sulfoconjugates in urine by LC-MS/MS
Susanna Vogliardi, Mariela Ivanova Marinova, Donata Favretto, Flavio Zancanaro, Santo Davide Ferrara
Forensic Toxicology and Antidoping, University Hospital of Padova, Via Falloppio 50, I-35121 Padova, Italy
• Abstract


AM-p-26 A method using an analyte trapping reagent, for the simultaneous analysis of the amino urinary metabolites of flunitrazepam, clonazepam and nitrazepam, by GC-MS
R.A.F. Couch and H.Madhavaram
LabPlus, Auckland City Hospital, Auckland, New Zealand
• Abstract


AM-p-27 High throughput extraction of drugs from biological fluids using an improved supported liquid extraction plate
Richard Calverley, Lee Williams, Scott Merriman, Helen Lodder, Anne Howells, Steve Jordan, Claire Desbrow, Matthew Cleeve
Argonaut Technologies, now a Biotage company, New Road, Hengoed, Mid Glamorgan, CF82 8AU, UK
• Abstract


AM-p-28 Analysis of inorganic impurities in illicit methamphetamine using Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
SungIll Suh1, Beom Jun Ko12, Yong Jun Suh1, Moon Kyo In1 and Sung-Hong Kim3
1Drug Signature Analysis Center, Supreme Prosecutors' Office, Seoul 137-730, Korea; 2School of Agricultural Biotechnology, Seoul National University, San 56-1, Sillim-dong, Gwanak-gu, Seoul, 151-742, Korea; 3Korea Basic Science Institute, Daegu branch, 1370, Sankyuk-dong, Puk-gu, Daegu, 702-701, Korea
• Abstract


AM-p-29 HPLC-ESI-MS/MS in bioanalytical chromatography: Can we forget chromatography?
Rainer W. Schmid and Lydia Halwachs
Medical & Chemical Labdiagnostics, University Hospital Vienna, Medical University of Vienna, Austria
• Abstract


Top
WORKPLACE DRUG TESTING & DOPING CONTROL
Platform Presentations
-
Poster Presentations
WD-o-01 Psychotropic Side-Effects of Anabolic Steroids
CM Müller-Platz1, RK Müller2, H. Michna3
1Federal Institute of Sports Science, Bonn; 2Institute of Doping Analysis and Sportsbiochemistry, Dresden; 3Institute of Public Health Research, Technical University Munich, Germany
• Abstract


WD-o-02 Analysis of Anabolic Steroids in Urine by LC/MS/MS
Michael C. Zumwalt1, John M. Hughes1, Matthew H. Slawson2, Chad R. Borges2 and Dennis J. Crouch2
1Agilent Technologies, Englewood, MS; 2Center for Human Toxicology, University of Utah, USA
• Abstract


WD-o-03 Determination of Opiates, Amphetamines, Cocaine, Phencyclidine, and Metabolites in Hair by LC-MS-MS
Min-Kun Huang, Choung-Huei Lee, Chiareiy Liu, Chun-Sheng Chien
National Bureau of Controlled Drugs, DOH, Taiwan, ROC
• Abstract


WD-o-04 Overview of the situation of workplace drug testing in Europe
Alain G Verstraete
Laboratory of Clinical Biology–Toxicology, Ghent University Hospital, and Department of Clinical Biology, Microbiology and Immunology, Ghent University, Belgium
• Abstract


WD-o-05 WORKPLACE DRUG TESTING: THREE YEARS EXPERIENCE IN THE FINNISH DEFENSE FORCES
Sirpa Mykkänen1, Pirjo Lillsunde1, Esa Meririnne2, Kyösti Lehtomäki2, Markus Henriksson1
1National Public Health Institute, Laboratory of Alcohol and Substance Abuse, Helsinki, Finland; 2Centre for Military Medicine, Finnish Defense Forces, Lahti, Finland
• Abstract


WD-o-06 Presence of THC-COOH in urine after drinking "Cannabis-beer"
Olof M.L.Beck1, Mats Brunes2, Michael Boettcher3
1Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden; 2Dependence Clinic, Karolinska Hospital, Stockholm, Sweden; 3Arxtpraxis f. Med. Mikrobiol., Dessau, Germany
• Abstract


Top
WORKPLACE DRUG TESTING & DOPING CONTROL
Poster Presentations
-
Platform Presentations
WD-p-01 Preliminary investigations of diuretic screening method converted from HPLC/MS to UPLC/MS
Russell Watts1, Philip Grace2, Michelle Wood1 and Simon Hudson2
1Waters Corporation, MS Technologies Centre, Manchester, UK; 2HFL, Fordham, Cambridgeshire, UK
• Abstract


WD-p-02 Methylnoretiocholanolone Sulfate – Long-Term Metabolite of Methylnortestosterone (17Α-Methylnandrolone)
Victor P. Uralets, Stacy A. Sweeney
Quest Diagnostics, 4230 Burnham Avenue, Las Vegas, Nevada 89119, USA
• Abstract


WD-p-03 Characterization of the Metabolites of New Designer Anabolic Steroids
Grigory Rodchenkov, Tim Sobolevsky and Vladimir Sizoi
Antidoping Centre, Elizavetinsky per.10, 105005, Moscow, Russia
• Abstract


WD-p-04 Metabolism of Non-Steroidal Phytoestrogens: Ipriflavone and 5-Methyl-isoflavones
Svetlana Appolonova*, Pavel Baranov, Grigory Rodchenkov
Antidoping Centre, Elizavetinsky per.10, 105005, Moscow, Russia
• Abstract
• Full Text

WD-p-05 Excretion Study of Methylprednisolone using HPLC-MS Ion Trap
Marina Dikunets, Svetlana Appolonova, Grigory Rodchenkov
Antidoping Centre, Elizavetinsky per.10, 105005, Moscow, Russia
• Abstract
• Full Text

WD-p-06 SPE-LC-TOFMS screening method for detection of doping agents in urine
M. Kolmonena1,2, A. Pelandera1, A. Leinonen2, I. Ojanperäa1
1Forensic Toxicology Division, Department of Forensic Medicine, University of Helsinki, Finland; 2Doping Control Laboratory, United Laboratories Ltd., Helsinki, Finland
• Abstract


Top
BEHAVIORAL TOXICOLOGY
Platform Presentations
-
Poster Presentations
BT-o-01 Prevalence of alcohol and illegal drugs in blood samples from drivers involved in traffic law violations: systematic review of the literature
Leonardo González Wilhelm1,2
1Center of Forensic Medicine, J.W. Goethe University, Frankfurt/Main, Germany; 2CIGES (Center of Training, Research and Management for Evidence-Based Health), Faculty of Medicine, Universidad de La Frontera, Temuco, Chile
• Abstract


BT-o-02 Cannabis and driving: results from a general population survey
F. Javier Álvarez, Inmaculada Fierro and M. Carmen del Río
Department of Pharmacology, Institute for Alcohol and Drug Studies, Faculty of Medicine, University of Valladolid, Spain
• Abstract


BT-o-03 Application of models for the prediction of time of marijuana exposure from blood of drivers arrested for DUI
Ann Marie Gordon, Rodney Gullberg and Barry K. Logan
Washington State Toxicology Laboratory, Seattle, WA, USA
• Abstract


BT-o-04 Age- and sex-related differences in blood- amphetamine concentrations in DUID suspects and reflections on drug- related impairment
Alan Wayne Jones
Department of Forensic Chemistry, Linköping, Sweden
• Abstract


BT-o-05 Driving Impairment from Dextromethorphan Abuse
Barry K. Logan1 and Chuck Hayes2
1Washington State Toxicology Laboratory, Seattle, WA, USA; 2IACP/DRE, Salem, OR, USA
• Abstract


BT-o-06 Risk of involvement in traffic accidents associated with the prescription of medicinal drugs: A registry-based cohort study
J. Mørland, S. Skurtveit and A. Engeland
Norwegian Institute of Public health, Oslo, Norway
• Abstract


Top
BEHAVIORAL TOXICOLOGY
Poster Presentations
-
Platform Presentations
BT-p-01 Mescaline effects on rat’s behaviour and the time profile of mescaline in rat serum and brain tissue after a single subcutaneous dose using GC-MS
T. Páleníček1, M. A. Balíková2
1Prague Psychiatric Center, Ústavní 91, 181 03 Prague 8 -Bohnice; 2Institute of Forensic Medicine and Toxicology, 1st Medical Faculty, Charles University in Prague, 121 08 Prague 2
• Abstract


BT-p-02 Concurrent measurements of arterial and venous blood alcohol concentrations and breath alcohol concentrations using the alcotest 7110 MK III Evidential
Katja Jachau, Holger Wittig, Dieter Krause
Institute of Forensic Medicine, Otto-von-Guericke University Magdeburg, Germany
• Abstract
• Full Text


BT-p-03 Determination of CDT. Comparison of ion exchange columns chromatography and capillary electrophoresis
Petra Finderle, Živa Flisar, Marija Prezelj
University Medical Centre Ljubljana, Institute of Clinical Chemistry and Biochemistry, Njegoševa 4, 1525 Ljubljana, Slovenia
• Abstract


BT-p-04 Effect of acetaldehyde on dopamine and dopamine-derived salsolinol in the brain of free-moving rats using in vivo Reverse Microdialysis Technique
Kiyoshi Ameno, Weihuan Wang, Mostofa Jamal, Mitsuru Kumihashi, Ikuo Uekita, and Iwao Ijiri
Department of Forensic Medicine, Kagawa University, Kagawa 761-0793, Japan
• Abstract


BT-p-05 Prevalence of alcohol and illegal drugs in blood samples from adults involved in traffic law violations in the area of Frankfurt/Main (Germany)
Leonardo González Wilhelm1,2, Juan José Orellana2, Gerold Kauert1, Hansjürgen Bratzke1
1Center of Forensic Medicine, J.W. Goethe University, Frankfurt/Main, Germany; 2CIGES (Center of Training, Research and Management for Evidence-Based Health), Faculty of Medicine, Universidad de La Frontera, Temuco, Chile
• Abstract


Top
ALTERNATIVE SPECIMENS
Platform Presentations
-
Poster Presentations
AS-o-01 Drugs in oral fluid in randomly selected drivers
Olaf H. Drummer, D. Gerostamoulos and M. Chu
Forensic and Scientific Services, Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, Melbourne, Australia
• Abstract


AS-o-02 Analysis of paired blood and oral fluid specimens from randomly selected nighttime drivers
Christine Moore1, John Lacey2 , Tara Kelley-Baker2, Cynthia Coulter1, Katharine Brainard2 , Debra Furr-Holden2, Sumandeep Rana1 and Michael Vincent1
1Immunalysis Corporation, 829 Towne Center Drive, Pomona, California 91767; 2Pacific Institute for Research & Evaluation, 11710 Beltsville Drive, Calverton, Maryland, 20705,USA
• Abstract


AS-o-03 Roadside drug testing in oral fluid – the Saarland experience
Thomas Kraemer1, Katrin Ettmueller1, Eva Prinz1, Hans-Juergen Maurer2 and Jochen Wilske1
1Institute of Legal Medicine, Saarland University, Homburg, Germany; 2Saarland State Police Department, Saarbruecken, Germany
• Abstract


AS-o-04 Confirmation by LC-MS of drugs in oral fluid obtained from Roadside testing
M. Concheiro, A. de Castro, O. Quintela, A. Cruz and M. López-Rivadulla.
Forensic Toxicology Service. Institute of Legal Medicine. University of Santiago of Compostela. Spain
• Abstract


AS-o-05 Use of oral fluid drug tests at the roadside: the results of the Rosita-2 study
A.Verstraete1, E. Raes2
1Laboratory of Clinical Biology–Toxicology, Ghent University Hospital; 2Department of Clinical Biology, Microbiology and Immunology, Ghent University, Belgium
• Abstract


AS-o-06 An evaluation of five rapid oral fluid drug-testing devices
Maria Kala, Wojciech Lechowicz, Piotr Adamowicz, Ewa Chudzikiewicz, Ewa Janowska and Maciej Kochanowski
Institute of Forensic Research in Krakow, Poland
• Abstract


AS-o-07 Development and validation of the Cozart® DDS Oral Fluid Collection Device
T. Speedy, D. Baldwin, G. Jowett, M. Gallina and A. Jehanli
Cozart Bioscience Ltd, Abingdon, Oxfordshire, England
• Abstract


AS-o-08 The recovery of illicit drugs from oral fluid sampling devices
Susan Nolan
Institute of Environmental Science and Research Limited, New Zealand
• Abstract


AS-o-09 Simultaneous determination of 6 amphetamines and analogues in hair and urine by LC-ESI-MS/MS: Application to the determination of MDMA after the absorption of a single dose of “Ecstasy”
M. Chèze, M. Deveaux and G. Pépin
Laboratoire TOXLAB, Paris, France
• Abstract


AS-o-10 Detection of diazepam in urine, hair and preserved oral fluid samples with LC-MS-MS after single and repeated administration of Myolastan® and Valium®
Marleen Laloup1, Maria del Mar Ramirez Fernandez1, Michelle Wood2, Gert De Boeck1, Viviane Maes3, Nele Samyn1
1National Institute of Criminalistics and Criminology; 2Waters Corporation; 3Academic Hospital AZ-VUB, Belgium
• Abstract


AS-o-11 Applications of arsenic speciation by HPLC-ICP/MS
P. Kintz, N. Marques, M. Ginet and V. Cirimele
Laboratoire ChemTox, Illkirch, France
• Abstract


AS-o-12 Ecstasy (MDMA) detected in 3 years old semen stains in a case of sexual assault
Peter X. Iten and Maja Zaugg
Institute of Legal Medicine, Dept. of Forensic Toxicology, Zurich, Switzerland
• Abstract


Top
ALTERNATIVE SPECIMENS
Poster Presentations
-
Platform Presentations
AS-p-01 The disposition into hair of a new designer drug, methylone and its related compounds
Ruri Kikura-Hanajiri
National Institute of Health Sciences, 1-18-1, Kamiyoga, Setagaya, 158-8501, Tokyo, Japan
• Abstract


AS-p-02 Determination of opioid analgesics in hair samples of patients under palliative care
F. Musshoff1, K. Lachenmeier1, U.Stamer2, F.F. Nauck3, B. Madea1
1Institute of Legal Medicine, Stiftsplatz 12, 53111 Bonn, Germany; 2Clinic of Anaesthesiology an Operative Intensive Care Medicine, University of Bonn, Sigmund-Freud-Straße 25, 53105 Bonn, Germany; 3Centre of Palliative Medicine, Malteser Hospital Bonn, Von-Hompesch-Straße 1, 53123 Bonn, Germany
• Abstract


AS-p-03 Patterns in drug use in the United Kingdom as revealed through analysis of hair in a large population sample
Lolita Tsanaclis, John Wicks
Tricho-Tech Limited, UK
• Abstract


AS-p-04 Evaluation of the IDS ONE-STEP&tm; Elisa kit for the detection of illicit drugs in hair specimens versus GC/MS
V Cirimele, ML Pujol, PJ Tritsch, M Villain, P Kintz
Laboratoire ChemTox, F-67400 Illkirch, France
• Abstract


AS-p-05 Routine drug of abuse monitoring in saliva with a new collection procedure and a modified homogenous immunoassays
Bettina Tuerk1,2, Dietmar Leichtfried2, Lydia Halwachs1, Rainer W. Schmid1
1Medical & Chemical Labdiagnostics, University Hospital Vienna, Medical University of Vienna, Austria; 2Greiner Bio-One, Kremsmuenster, Austria
• Abstract


AS-p-06 Method development and validation for analysis of amphetamine, methamphetamine, methylenedioxy derivatives and metabolites in sweat patches using disk solid-phase extraction and gas chromatography-mass spectrometry
Bruno S. De Martinis1, Allan J. Barnes2, Karl B. Scheidweiler2 and Marilyn A. Huestis2*
1Department of Pathology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Center of Legal Medicine, Ribeirão Preto, SP, 14051-140, Brazil; 2Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, 5500 Nathan Shock Dr., Baltimore, MD 21224, USA
• Abstract


Top
POST-MORTEM TOXICOLOGY
Platform Presentations
-
Poster Presentations
PT-o-01 Postmortem cases involving amphetamine-based drugs in the Netherlands
Miranda Verschraagen, Ann Maes, Bart Ruiter, Ingrid J. Bosman, Beitske E. Smink and Klaas J. Lusthof
Netherlands Forensic Institute, Department of Pathology and Toxicology, The Hague, The Netherlands
• Abstract


PT-o-02 Reference postmortem concentrations of antidepressant drugs reflected in a therapeutic material.
Margareta Reis1, Trond Aamo2, Johan Ahlner3 and Henrik Druid4
1Dept of Clinical Pharmacology, Linköping University Sweden; 2Dept of Clinical Pharmacology, Trondheim University Hospital, Norway; 3Dept of Forensic Chemistry, National Board of Forensic Medicine, Linköping, Sweden; 4Dept of Forensic Medicine, Karolinska Institute, Stockholm, Sweden
• Abstract


PT-o-03 Liquid chromatography-multiple mass spectrometry determination of atracurium and laudanosine in a case of suspected multi-homicide
Donata Favretto, Mariela Ivanova, Alessandro Nalesso, Franca Castagna and Santo Davide Ferrara
Forensic Toxicology and Antidoping, University Hospital of Padova, Padova, Italy
• Abstract


PT-o-04 Analytical toxicology of 3-methylfentanyl related deaths
Ilkka Ojanperä1, Merja Gergov1, Milana Liiv2, Aime Riikoja2 and Erkki Vuori1
1Department of Forensic Medicine, University of Helsinki, Finland, 2Estonian Bureau of Forensic Medicine, Tallinn, Estonia
• Abstract


PT-o-05 Postmortem redistribution of cannabinoids: first results of a study performed in a pig model
B. Brunet1,2, F. Favreau13, T. Hauet13, W. Hebrard4, Y. Papet2, G. Mauco13, P. Mura2
1INSERM E-0324, Poitiers, France; 2Centre hospitalier universitaire Laboratoire de toxicologie et pharmacocinétique, Poitiers, France; 3Centre hospitalier universitaire Laboratoire de Biochimie, Poitiers, France; 4INRA, GEPA Laboratoire de chirurgie expérimentale, Surgères, France
• Abstract


PT-o-06 A study of multiple-drug suicides involving oxycodone
M. Deveaux and G. Pépin
Laboratoire TOXLAB, F-75018 Paris, France
• Abstract


PT-o-07 Fatal intoxication by butenes: HS-GC/FID and HS-GC/MS determination of butene isomers in bio-fluids and tissues
Alessandro Nalesso, Donata Favretto, Claudio Terranova, Sergio Maietti, Santo Davide Ferrara
Forensic Toxicology and Antidoping, University Hospital of Padova, Padova, Italy
• Abstract


PT-o-08 Ethyl glucuronide in blood as a marker of ante-mortem ingestion of alcohol; possibility of false negative results
G.Høiseth, R.Karinen, A.Christophersen, L.Johnsen, P.T.Normann and J.Mørland
Norwegian Institute of Public Health, Division of Forensic Toxicology and Drug Abuse, Oslo, Norway
• Abstract


PT-o-09 Analysis of 2,4-dinitrophenol and its phase I and phase II metabolites in a case of fatal poisoning using a 4000 QTrap LC-MS-MS system
Lucia Politi, Claudia Vignali and Aldo Polettini
Department of Legal Medicine & Public Health, University of Pavia, Italy
• Abstract


PT-o-10 Accidental death following inadvertent perfusion of zinc oxide shake lotion
Fritz Pragst, Andreas Correns, Friedrich Priem, Sieglinde Herre and Hubert Martin
Institute of Legal Medicine, University Hospital Charité, Berlin, Germany
• Abstract


PT-o-11 Fatality involving vinblastine overdose as a result of a complex medical error
Małgorzata Kłys, Tomasz Konopka, Mariusz Ścisłowski, Piotr Kowalski
Department of Toxicology, Institute of Forensic Medicine, Collegium Medicum, Jagiellonian University, Krakow, Poland
• Abstract


Top
POST-MORTEM TOXICOLOGY
Poster Presentations
-
Platform Presentations
PT-p-01 Suicidal inhalation of motorbike exhaust: adding new data to the literature about the contribution of gasoline to the cause of death
María A. Martínez1 and Salomé Ballesteros2
1Chemistry Department; 2Spanish Poison Control Center, National Institute of Toxicology and Forensic Sciences, Ministry of Justice, C/ Luis Cabrera 9, 28002 Madrid, Spain
• Abstract


PT-p-02 A fatal intoxication with the antimalarial drug chloroquine
Nicolas Vrydags1, Kathleen Croes1, Jan Bolt2 and Frank Martens1
1Department of Forensic Toxicology, AZ Groeninge, Kortrijk, Belgium; 2Forensic pathologist, Kruishoutem, Belgium
• Abstract


PT-p-03 Fatal case at a workplace involving fluosilicate of zinc
Teresa Lech
Institute of Forensic Research, 31-033 Krakow, Poland
• Abstract
• Full Text


PT-p-04 The value of brain specimens in post-mortem forensic toxicology
Thomas Stimpfl and Sabine Reichel
Department of Forensic Medicine, Medical University of Vienna, Sensengasse 2, A-1090 Vienna, Austria
• Abstract


PT-p-05 A novel protocol for the analysis of diltiazem to aid interpretation
Simon Elliott, Collin Seneviratne
Regional Laboratory for Toxicology, City Hospital, Birmingham, UK
• Abstract


PT-p-06 Levamisole as a contaminant of illicit Cocaine
Morley S.R., Forrest A.R.W. , Galloway J.H.
Toxicology Section, Sheffield Teaching Hospital Foundation Trust, Sheffield, S10 2JF, United Kingdom
• Abstract


PT-p-07 Zolpidem in lethal cases
Marie Staňková, Petr Kurka
Institute of Forensic Medicine, University Hospital Ostrava, Czech Republic
• Abstract
• Full Text


PT-p-08 Rapid determination of methadone in postmortem whole blood and cerebellum
Birgit Reiter
Department of Forensic Medicine , Sensengasse 2, A-1090 Vienna, Austria
• Abstract
• Full Text


PT-p-09 A comparative study on the production of ethyl and methyl alcohol in post mortem specimens (blood, brain tissue and muscle)
I. A. Alabdooli1, F.A. Tarbah1, F.A. Benomran1 and Th. Daldrup2
1Dubai Police H.Q. Forensic Science Dept. P.O. Box 1493, Dubai, U.A.E; 2Institute of Legal Medicine, Heinrich-Heine-University, Duesseldorf, Germany
• Abstract
• Full Text


PT-p-10 Analysis of paraquat in post-mortem specimens of a paraquat-related death by HPLC
Chyh Yeng Tan, Hsiao Tung Leong, Tian Hwee Koh, Eugene W. S. Goh, Yi Ju Yao, Danny S.T. Lo
Toxicology Laboratory, Centre for Forensic Science, Health Sciences Authority, 11 Outram Road, Singapore
• Abstract


PT-p-11 Postmortem femoral blood concentrations of opiates
Fredrik C. Kugelberg, Henrik Druid
Department of Forensic Medicine, Karolinska Institutet, Stockholm, Sweden, and The National Board of Forensic Medicine, Linköping, Sweden
• Abstract


PT-p-12 Distribution of dimethoate in the body after a fatal organophosphate intoxication
F. A. Tarbah1, F.A. Benomran1, A. I. Hassan1, A.M. Shaheen1 and Th. Daldrup2
1Dubai Police H.Q, Forensic Science Dept. P.O. Box 1493, Dubai, U.A.E; 2Institute of Legal Medicine, Heinrich-Heine-University, Duesseldorf, Germany
• Abstract


PT-p-13 Toxicological analysis after asphyxial suicide with helium and a plastic bag
V. Auwärter, M. Große Perdekamp, J. Kempf, W. Weinmann, U. Schmidt, S. Pollak
Institute of Legal Medicine, University Hospital Freiburg
• Abstract


PT-p-14 Nefopam Fatality
Julie Elizabeth Midgley, Helen Poulsen
Institute of Environmental Science and Research, PO Box 50-348, Porirua, New Zealand
• Abstract


PT-p-15 Fatal single-vehicle chrash under the influence of ketamine and alcohol
Y Barguil1, M Deveaux2, S Mermond1, M Chèze1, E Choblet1, G Pépin2
1Biochemistry Laboratory, New Caledonia Territorial Hospital, 98849 Noumea, New Caledonia; 2Laboratoire TOXLAB, F-75018 Paris, France
• Abstract


PT-p-16 A database for forensic toxicology available via Internet.
Johan Ahlner1, Margareta Reis2, Henrik Druid3
1Dept of Forensic Toxicology, National Board of Forensic Medicine, Linköping, Sweden; 2Dept of Clinical Pharmacology, Linköping University, Sweden; 3Dept of Forensic Medicine, Karolinska Institute, Stockholm, Sweden
• Abstract


PT-p-17 Method for Quantification of Opioids and their Metabolites in Autopsy Blood by Liquid Chromatography-Tandem Mass Spectrometry
Ahmed I. Al-Asmari and Robert A. Anderson
University of Glasgow, UK
• Abstract


PT-p-18 A case report: Tianeptine (STABLON®) related death
P. Proença1, H.M. Teixeira1,2, J.Pinheiro1, A. Claro1, P.V. Monsanto1, D.N. Vieira1,2
1National Institute of Legal Medicine, Coimbra, Portugal; 2Faculty of Medicine, Coimbra University, Coimbra, Portugal
• Abstract


PT-p-19 Determination and distribution of clotiapine (Entumine®) in human plasma, postmortem blood and tissue samples from clotiapine treated patients and from autopsy cases
Frank Sporkert1, Marc Augsburger1, Christian Giroud1, Clarisse Brossard1, Chin B. Eap2 and Patrice Mangin1
1Institut Universitaire de Médecine Légale, Rue du Bugnon 21, CH-1005 Lausanne, Switzerland; 2Unité de Biochimie et Psychopharmacologie Clinique, Département Universitaire de Psychiatrie Adulte et
• Abstract


Top
OCCUPATIONAL & ENVIRONMENTAL TOXICOLOGY
Platform Presentations
-
Poster Presentations
OE-o-01 Microcystis Aeruginosa and microcistyns in the Rio de la Plata
L. Giannuzzi1, D.Andrinolo1, M. Caneo1, M. Di Lorenzo1, R.Echenique2, M.Barco3, J.Rivera3 and J.Caixach1
1Cátedra de Toxicología y Química Legal Facultad de Ciencias Exactas, Universidad Nacional de La Plata (UNLP), La Plata, Argentina; 2Departamento de Ficología, Facultad de Ciencias Naturales y Museo. UNL; 3Laboratorio de Espectrometria de Masas, Departamento de Ecotecnología , Barcelona , España
• Abstract


OE-o-02 Mercury Impact on the Health of Miners in the Idrija Mercury Mine after the Second World War
Alfred Bogomir Kobal
Department of Occupational Medicine, Idrija Mercury Mine, Idrija, Slovenia
• Abstract


Top
OCCUPATIONAL & ENVIRONMENTAL TOXICOLOGY
Poster Presentations
-
Platform Presentations
OE-p-01 Glutathione and mercury conjugate with glutathione in ex-miners' erythrocytes
Marija Prezelj1, Mladen Krsnik1, Milena Horvat2, Alfred B. Kobal1
1Clinical Institute of Clinical Chemistry and Biochemistry, Medical Centre Ljubljana, Slovenia; 2J.Stefan Institute, Jamova 39, Ljubljana, Slovenia
• Abstract


OE-p-02 Pineal hormone melatonin level in ex-mercury miners
Joško Osredkar1, Milena Horvat2, Mladen Krsnik1, Darja Kobal3, Bernard Ženko2, Sašo Džeroski2 and Alfred B. Kobal1
1Clinical Institute of Clinical Chemistry and Biochemistry, Medical Centre Ljubljana, Slovenia; 2J.Stefan Institute, Jamova 39, Ljubljana, Slovenia; 3Department of Psychology, University of Ljubljana, Ljubljana
• Abstract


OE-p-03 Preliminary study on possible influence of elemental mercury during pregnancy
M. Krsnik2, A.B. Kobal2, M. Horvat3, M. Prezelj2, A. Briski2, D. Gibicar3, C. Knap1 and J. Osredkar2
1Idrija Mercury Mine, Idrija, Slovenia; 2University Medical Centre Ljubljana, Institute of Clinical Chemistry and Biochemistry, Ljubljana, Slovenia; 3Jozef Stefan Institute, Ljubljana, Slovenia
• Abstract


OE-p-04 Elemental mercury vapour and small nerve fibre function
Duska Meh1, Alfred B. Kobal2
1Institute for Rehabilitation and Department for Physical and Rehabilitation Medicine, Medical Faculty Ljubljana, Linhartova 51, 1000 Ljubljana, Slovenia; 2Department of Occupational Medicine, Idrija Mercury Mine, Idrija, Slovenia
• Abstract


OE-p-05 Biological monitoring of ortho-toluidine in occupational exposure
L. Labat1, J. Thomas1, B. Dehon1, L. Humbert1, B. Leleu2, C. Nisse3, M. Lhermitte1
1Laboratoire de Toxicologie et Génopathies, CHRU de Lille, France; 2Sita Agora, Noyelles Gaudolt, France; 3Service de Pathologie Professionnelle et Environnement, CHRU de Lille, France
• Abstract


OE-p-06 Alteration in the immunotoxicity of LOEL dose of dimethoate on combined exposure with NOEL doses of cypermethrin and amitraz in rats in a subacute experimental system
L. Institóris1, I.K. Kecskeméti1, Dóra Kovács1, Anita Lukács2, Andrea Szabó2, Zsuzsanna Lengyel2, A. Papp2
1Dept. Forensic Medicine, Szeged, Hungary; 2Dept. Public Health, Fac. Medicine, Univ. Szeged, Szeged, Hungary
• Abstract


Top
CLINICAL FORENSIC TOXICOLOGY
Platform Presentations
-
Poster Presentations
CT-o-01 Alfred Swaine Taylor MD FRS (1806-1880)
Robert James Flanagan1 and Katherine Watson2
1Medical Toxicology Unit, Guy's & St Thomas' NHS Trust, London, UK, 2School of Arts & Humanities, Oxford Brookes University, Oxford, UK
• Abstract


CT-o-02 Toxicological aspects in relation to the drug transporter P- glycoprotein at the blood-brain barrier
Kristian Linnet and Thomas B. Ejsing
The Dept of Forensic Chemistry, University of Copenhagen, Denmark
• Abstract


CT-o-03 Biotechnological synthesis of drug metabolites using P450-expressing fission yeast – new perspectives in metabolism studies for 4’methyl-α-pyrrolidinobutyrophenone
Frank T. Peters1, Calin-Aurel Dragan2, Markus R. Meyer1, Matthias Bureik2, and Hans H. Maurer1
1Department of Experimental and Clinical Toxicology, Saarland University, Homburg (Saar), Germany; 2PomBioTech, Saarbruecken, Germany
• Abstract


CT-o-04 Systematic Toxicological Analysis of Xenobiotics – Comparison of the results obtained on patient samples using immunoassays, LC/DAD and LC/MS methods
M. Lhermitte1, M. Wood2, L. Humbert1, G. Bondoux3
1Laboratoire de Toxicologie & Génopathies, Hôpital Calmette - CHRU de Lille, Lille Cedex – France; 2Waters Corporation, Atlas Park, Manchester, U.K; 3Waters Corporation, European Headquarters Waters S.A.S., Guyancourt - France
• Abstract


CT-o-05 Development of a fully automated screening system for the determination of basic compounds in urine by on-line extraction – high performance liquid chromatography with photodiode-array detection
Lena Schönberg1,2, Thomas Grobosch2, Dagmar Lampe2 and Charlotte Kloft1,3
1Department of Clinical Pharmacy, Institute of Pharmacy, Freie Universitaet Berlin, Berlin, Germany; 2Berliner Betrieb fuer Zentrale Gesundheitliche Aufgaben (BBGes), Institute of Clinical Toxicology – Clinical Toxicology and Poison Control Centre, Berlin, Germany; 3Department of Clinical Pharmacy, Faculty of Pharmacy, Martin-Luther-Universitaet Halle-Wittenberg, Germany
• Abstract


CT-o-06 Maternal methadone dose, methadone meconium concentrations, severity of neonatal abstinence syndrome and other birth outcomes
Robin E. Choo1, Hendrée E. Jones2, Jennifer R. Schroeder3 and Marilyn A. Huestis1
1Chemistry and Drug Metabolism, Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA; 2Center for Addiction and Pregnancy, Johns Hopkins Bayview Medical Center; 3Office of the Clinical Director, Intramural Research Program, National Institute on Drug Abuse, National Institute of Health, Baltimore, MD, USA
• Abstract


CT-o-07 Toxicological analysis and toxicokinetics in an acute fluoxetine and trimipramine intoxication
Thomas Grobosch and Dagmar Lampe
Berliner Betrieb für Zentrale Gesundheitliche Aufgaben (BBGes), Institute of Toxicology Clinical Toxicology and Poison Control Center Berlin, Berlin, Germany
• Abstract


CT-o-08 Determination of ergotamine in hair, plasma and urine samples by liquid chromatography - tandem mass spectrometry
Donata Favretto, Giampietro Frison, Susanna Vogliardi and Santo Davide Ferrara
Forensic Toxicology and Antidoping, University Hospital of Padova, Padova, Italy
• Abstract


CT-o-09 Within-subject variability of alcohol pharmacokinetic parameters
Donald Noel Sims1, Jaimi Burns1 Lisa Yelland2, Amy Salter2 and Jason White3
1Forensic Science SA; 2Department of Public Health, The University of Adelaide; 3Department of Clinical and Experimental Pharmacology, The University of Adelaide
• Abstract


CT-o-10 Kinetics of ethyl sulfate and ethyl glucuronide after medium dose ethanol
Claudia C. Halter1, Volker Auwaerter1, Haiko Schloegl1, Sebastian Dresen1, Friedrich M. Wurst2 and Wolfgang Weinmann1
1Institute of Forensic Medicine, University Hospital, Freiburg, Germany; 2Psychiatric University Clinic Basel, Basel, Switzerland
• Abstract


CT-o-11 Sensitivity and specificity of ethyl glucuronide in hair as a marker of chronic heavy alcohol use- preliminary results
Aldo Polettini, Luca Morini, Cristiana Stramesi and Lucia Politi
Department of Legal Medicine & Public Health, University of Pavia, Pavia, Italy
• Abstract


CT-o-12 Predictive value of CDT (carbohydrate-deficient transferrin) in assessing fitness to drive
Raffaele Giorgetti, Lorenzo Luporini, Stefania Pagani, Adriano Tagliabracci
Dipartimento di Neuroscienze, Sezione di Medicina Legale, Università Politecnica delle Marche, Ancona, Italy
• Abstract


Top
CLINICAL FORENSIC TOXICOLOGY
Poster Presentations
-
Platform Presentations
CT-p-01 The Extent and Mortality of Insecticide Related Acute Poisoning in Upper Egypt
Magda H. El-Karadawy1, Soheir A. Mohamed2, Nady S. Aly1, Khaled M. Mohamed1
1Medico-Legal Department, Ministry of Justice, Egypt; 2Forensic Medicine and Toxicology, Faculty of Medicine, South Valley University
• Abstract


CT-p-02 Effects of Ciprofloxacin on testis apoptosis and sperm parameters in rat
Marefat Ghaffari Novin, Mahnaz Heidari, Arash Khaki
Reproductive Biotechnology Center, Avesina Research Institute, Tehran, Iran
• Abstract


CT-p-03 A novel method for Automated Detection and Identification of Toxicological relevant compounds in Urine and Serum samples using a GC/MS/NPD system
Bernhard Rothweiler
Agilent Technologies, Waldbronn, Germany
• Abstract


CT-p-04 Successful suicide with oxygen using a facial mask at hospital – A case report
P. Mura1, M. Sapanet2, P. Kintz3
1Laboratoire de Toxicologie et Pharmacocinétique, CHU, Poitiers, France; 2Service de Médecine Légale, CHU, Poitiers, France ; 3Laboratoire ChemTox, Illkirch, France
• Abstract


CT-p-05 Acute Deliberate Organophosphate (Coumaphos) Poisoning With Intermediate Syndrome in a One Year Old Child
Kiat, W.K.
Toxicology Unit, St. Luke’s Medical Center, Quezon City, Philippines
• Abstract


CT-p-06 Rapid and selective analysis of nicotine and cotinine in urine by using HPLC-UV with post-column photo-irradiation
Jennifer P. Pascali, Federica Bortolotti, Rossella Gottardo, Franco Tagliaro
Department of Medicine and Public Health, Unit of Forensic Medicine, University of Verona, Verona, Italy
• Abstract


CT-p-07 Citalopram in newborns: A case report
Eva Novakova
Institute of Forensic Medicine and Toxicology, 1st Medical School and Hospital, Charles University, Prague, Czech Republic
• Abstract
• Full Text


CT-p-08 Analysis of Carbohydrate-Deficient Transferrin (CDT) as a marker of chronic alcohol abuse. Comparative Evaluation of a Commercial Fully Automated Multicapillary Electropherograph with a Single Capillary Electropherograph
Giorgia De Paoli, Federica Bortolotti, Jennifer P. Pascali, Franco Tagliaro
Department of Medicine and Public Health, Unit of Forensic Medicine, University of Verona, Verona, Italy
• Abstract


CT-p-09 A systematic and comprehensive method for general toxicological screening using QTrap LC-UV-MS-MS
Simon Elliott1, Frans Schoutsen2, Bénédicte Duretz3
1Regional Laboratory for Toxicology, Birmingham, United Kingdom; 2Applied Biosystems, Warrington, United Kingdom; 3Applied Biosystems, Les Ulis, France
• Abstract


CT-p-10 Case report: Ethylene glycol poisoning
Lovrić M1, Granić P1, Čubrilo-Turek M2, Lalić Z1, Sertić J1
1Clinical Institute of Laboratory Diagnosis, Zagreb University Hospital Center, Zagreb, Croatia; 2Department of Internal Medicine, “Sveti Duh” General Hospital, Zagreb, Croatia
• Abstract


CT-p-11 Fast HPLC-DAD method for simultaneous phenotyping of CYP2C19 and CYP3A4 through the determination of omeprazole and two of its metabolites in human plasma samples
Rafael Linden1, André Arigony Souto2
1Centro Universitário Feevale; 2Pontifícia Universidade Católica do Rio Grande do Sul
• Abstract


CT-p-12 Forensic Toxicology in South Africa: scope, trends and challenges
A. A. Grové1, A.S. Schillack2 , I.J. Fenyvesi3 and M.J. Stewart4
1Department of Health: Forensic Chemistry Laboratory, Private Bag X282, Pretoria 0001, South Africa; 2Department of Health: Forensic Chemistry Laboratory, P. O. Box 668, Woodstock, Cape Town 8000, South Africa; 3Department of Health: Forensic Chemistry Laboratory, P.O. Box 1080, Johannesburg 2000, South Africa; 4Director: Forensic Pathology Services, Department of Health, Private Bag X828, Pretoria 0001, South Africa
• Abstract


CT-p-13 Platinum levels in various tissues of a patient died 181 days after cisplatin overdose determined by electrospray ionization mass spectrometry
Kayoko Minakata, Osamu Suzuki
Hamamatsu University School of Medicine, Japan
• Abstract
• Full Text


CT-p-14 Simple screening tests of poisons for clinical and forensic laboratory in Japan
Kojiro Kimura
Department of Legal Medicine, Hiroshima University, Japan
• Abstract


CT-p-15 Fulminant liver failure in a patient on carbamazepine and levetiracetam treatment
G. Skopp1, H. P. Schmitt2, I. Pedal1
1Institute of Legal and Traffic Medicine, Voss-Str. 2, 69125 Heidelberg, Germany; 2Institute of Pathology, Im Neuenheimer Feld 220/221, 69120 Heidelberg, Germany
• Abstract
• Full Text


CT-p-16 Difficulties and Pitfalls in Analysis of Benzodiazepines
Kateřina Zedníková, Peter Ondra
Faculty Hospital, Institute of Forensic Medicine and Medical Law, Hněvotínská 3, 775 09, Olomouc, Czech Republic
• Abstract
• Full Text


CT-p-17 Histopathological Effects of Chronic Opium Dosage on Normal and Diabetic Rats: Effects on the Liver and Kidney
Hatem Abdel Monem Ahmed1, Alaa M. Alanwar2, E. H. El Gawish3, Shaaban M. Ahmed4, M. H. Ibrahem5
1Assiut Lab. of Midico-legal Department, Egypt; 2Ministry of Justice, Egypt; 3Assuit Branch, Egypt; 4Zoology Department, Faculty of science, Elmenia University, Egypt
• Abstract


CT-p-18 Drug-facilitated sexual assault provoked by the victim’s religious beliefs: A rare case report
C. Maravelias, M. Stefanidou, A. Dona, S. Athanaselis and Ch. Spiliopoulou
Department of Forensic Medicine and Toxicology, University of Athens, Medical School, 75 Mikras Asias street, Goudi, Athens 115 27 Greece
• Full Text


Top
DRUGS OF ABUSE
Platform Presentations
-
Poster Presentations
DA-o-01 Identification of human monoamine oxidases A/B and cytochrome P450 2D6 as major enzymes involved in the main metabolic steps of phenethylamine-derived designer drugs (2c-series)
Denis S. Theobald and Hans H. Maurer
Department of Experimental and Clinical Toxicology, University of Saarland, Homburg (Saar), Germany
• Abstract


DA-o-02 Designer drug TMA-2: studies on the metabolism including CYP isoform dependency and on the toxicological detection
A.H. Ewald1, G. Fritschi2, and H.H. Maurer1
1Department of Experimental and Clinical Toxicology, University of Saarland, Homburg (Saar); 2Hessisches Landeskriminalamt, Wiesbaden, Germany
• Abstract


DA-o-03 Suspension Bead Array (SBA) technology as a presumptive tool in testing for amphetamine- type substances and designer analogues
Luigino Apollonio1, Jennelle Kyd1, Ian Whittall2, Dennis Pianca2, William Maher1
1National Centre for Forensic Studies, University of Canberra, Bruce ACT, Australia; 2Department of Toxicology and Forensic Chemistry, ACT Government Analytical Laboratory, Weston Creek ACT, Australia
• Abstract


DA-o-04 Urinary elimination of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (CTHC) after its intravenous application
L. Dietz1, A. Glaz-Sandberg2, H. Nguyen3, G. Mikus2 und R. Aderjan1
1Institute of Legal Medicine and Traffic Medicine; 2Dept of Internal Medicine VI, Clinical Pharmacology and Pharmacoepidemiology; 3University Hospital Pharmacy, University of Heidelberg, Heidelberg Germany,
• Abstract


DA-o-05 GHC serum concentrations and pitfalls of interpretation
Susanne Vogt, Maren Hermanns-Clausen, Jessica Traber, Wolfgang Weinmann
Institute of Forensic Medicine, University Hospital Freiburg, Freiburg, Germany
• Abstract


DA-o-06 Further evidence of in vitro production of endogenous GHB in urine samples
Marc LeBeau, Madeline Montgomery, Cynthia Morris-Kukoski, Jason Schaff, Anna Deakin
FBI Laboratory, Chemistry Unit, Quantico, VA, USA
• Abstract


DA-o-07 Internet monitoring: Getting high by pharmaceutical tampering
Edward J. Cone1, Sidney Schnoll1, John Pinney1, Jack E. Henningfield1, Reginald V. Fant, Bruce A. Goldberger2 and Chris W. Chronister2
1Pinney Associates, Bethesda, MD, USA; 2University of Florida College of Medicine, Gainesville, FL, USA
• Abstract


DA-o-08 An unusual case of DFSA using aromatic solvents
María A. Martínez1 and Salomé Ballesteros2
1Chemistry Department, 2Spanish Poison Control Center, National Institute of Toxicology and Forensic Sciences, Ministry of Justice, Madrid, Spain
• Abstract


DA-o-09 Compliance testing in methadone substitution therapy: evaluation of CEDIA EDDP taking account of methadone dose, urinary pH, creatinine and CEDIA Sample Check
Michael Boettcher1, Christian Jellinek2, Olof Beck3
1Arztpraxis für Medizinische Mikrobiologie und Labordiagnostik, Dessau, Germany; 2Ambulanz für Integrierte Drogenhilfe Neukoelln, Berlin, Germany; 3Department of Clinical Pharmacology, Karolinska Institute, Stockholm, Sweden
• Abstract


DA-o-10 A validation of meconin as an indicator for illicit opiate use
John H. Galloway, A. Robert W. Forrest and Stephen R. Morley
Department of Clinical Chemistry, Royal Hallamshire Hospital, Sheffield, Great Britain.
• Abstract


DA-o-11 Proof of a 1-(3-chlorophenyl)piperazine (mCPP) intake - Use as adulterant of cocaine resulting in drug – drug interactions?
Roland F. Staack, Liane D. Paul, Dagmar Schmid, Gabriele Roider, Burkhard Rolf
Institute of Forensic Medicine, University of Munich, Germany
• Abstract


DA-o-12 Heroin drugged drivers: Role of morphine and morphine-6-glucuronide in clinical impairment
Liliana C. Bachs, Gudrun Høiseth, Svetlana Skurtveit and Jørg Mørland
Norwegian Institute of Public Health, Oslo, Norway
• Abstract


Top
DRUGS OF ABUSE
Poster Presentations
-
Platform Presentations
DA-p-01 Driving under the influence in Greece: A seven year survey (1998-2004)
Papadodima S., Athanaselis S., Maravelias K., Dona A., Stefanidou M., Papoutsis, J., Spiliopoulou C.
Dept.of Forensic Medicine and Toxicology, School of Medicine, University of Athens, Greece
• Abstract
• Full Text


DA-p-02 Elimination of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol (CTHC) and formation and elimination of its acyl-glucuronide (CTHC–Glu) in serum after intravenous application of 5 mg
R. Aderjan1, L. Dietz1, A. Glaz-Sandberg2, H. Nguyen3, G. Mikus2
1Institute of Legal Medicine and Traffic Medicine; 2Dept of Internal Medicine VI, Clinical Pharmacology and Pharmacoepidemiology; 3University Hospital Pharmacy, University of Heidelberg, Germany
• Abstract


DA-p-03 Quantitative determination of major cutting agents in cocaine samples seized in Slovenia in the period from May 2004 to November 2005
Tomaž Gostič
Ministry of the Interior, Forensic Research Center, Ljubljana, Slovenia
• Abstract


DA-p-04 Interactions among the components in amphetamine-type stimulant tablets in human intestinal Caco-2 cells and in oral administration to rats
Kenji Kuwayama1, Kenji Tsujikawa1, Hajime Miyaguchi1, Tatsuyuki Kanamori1, Yuko Iwata1, Hiroyuki Inoue1, Tohru Kishi1, Seiji Miyauchi2, Naoki Kamo1
1National Research Institute of Police Science; 2Laboratory of Biophysical Chemistry, Graduate School of Pharmaceutical Sciences, Hokkaido University
• Abstract


DA-p-05 Characterization of Volatile Components of Marijuana and Hashish (Cannabis Sativa L.)
Yuko T. Iwata, Hiroyuki Inoue, Kenji Kuwayama, Tatsuyuki Kanamori, Kenji Tsujikawa, Hajime Miyaguchi and Tohru Kishi
National Research Institute of Police Science, 6-3-1, Kashiwanoha, 277-0882, Kashiwa, Japan, Chiba
• Abstract


DA-p-06 Analysis of Ketamine & Norketamine in Urine by Automatic Solid-Phase Extraction (SPE) and Positive ion chemical ionization–gas chromatography-mass spectrometry (PCI-GC-MS)
Eunmi Kim, Juseon Lee, Sangkil Choi, Miae Lim and Heesun Chung
National Institute of Scientific Investigation, Korea
• Abstract


DA-p-07 Evaluation of a homogenous urine immunoassay for the determination of methadone in serum samples
Michael Boettcher, Stefan Lierheimer
Arztpraxis für Medizinische Mikrobiologie und Labordiagnostik, Dessau, Germany
• Abstract


DA-p-08 GC/MS Analysis of Ketamine in urine of sexual assault victims
Shanlin Fu, John Lewis
PaLMS, Northern Sydney Central Coast Area Health, NSW, Australia
• Abstract


DA-p-09 A screening method using LC-MS/MS for illicit drugs in plasma and postmortem blood
Akgür S.A., Dolma C., Ertaş H., Moral A.R.
Ege University Poison Research and Application Center, Bornova, 35100, İzmir, Turkey
• Abstract


DA-p-10 Validation of the new CEDIA THCplus urine immunoassay
M.Boettcher1, A.Peschel1, W.Haase2
1Arztpraxis für Medizinische Mikrobiologie und Labordiagnostik, Dessau, Germany; 2MEDILYS, Zentrallabor Klinikum Nord, Hamburg, Germany
• Abstract


DA-p-11 Estrogenic Effect of Marijuana Smoke Condensate
Sooyeun Lee1,2, Heesun Chung1, Seungmin Oh2, Taejung Kwon1, Chunsam Kim1, Sangki Lee1, Kyuhyuck Chung2
1National Institute of Scientific Investigation, Seoul 158-707, Korea; 2Sungkyunkwan University, Gyeonggi-do 440-746, Korea
• Abstract


DA-p-12 Detection of Δ9-Tetrahydrocannabinolic acid in human urine and human blood serum by LC/MS/MS and GC/MS
Julia Jung, Juergen Kempf, Wolfgang Weinmann
Institute of Legal Medicine, Forensic Toxicology, University Hospital, Freiburg
• Abstract


DA-p-13 Distribution characteristics of 2,5-dimethoxy-4-bromoamphetamine (DOB) in rats after oral and subcutaneous administration
Katerina Berankova, Marie Balikova
Institute of Forensic Medicine and Toxicology, 1st Medical Faculty, Charles University in Prague
• Abstract


DA-p-14 Adulterants in Heroin Seized in the Canton Bern Switzerland
Werner Bernhard, Alain Broillet, Franziska Luginbühl, Priska Regenscheit
Institute of Legal Medicine, University of Bern, Buehlstrasse 20, 3012 Bern, Switzerland
• Abstract
• Full Text


DA-p-15 Combined abuse of liquid ecstasy and amphetamines in duid cases
Wolfgang Weinmann, Sebastian Dresen, Jürgen Kempf
Institute of Forensic Medicine, University Hospital Freiburg, Albertstr. 9, D 79104 Freiburg, Germany
• Abstract


DA-p-16 Analysis of certain cannabinoid metabolites in urine samples from Hungary by GC/MS after alkaline and enzymatic hydrolysis
Előd Hidvégi1, Edit Penczi1, Zsuzsa Hideg1, Douwe de Boer2, Gábor Somogyi1
1National Institute of Forensic Toxicology, Budapest, Hungary; 2Department of Clinical Chemistry, University Hospital Maastricht, Maastricht, The Netherlands
• Abstract


DA-p-17 Quantification of cocaine and benzoylecgonine in wastewater by gas chromatography-mass spectrometry: mapping cocaine abuse in the Belgian university city of Leuven
Dieter Waumans, Steven Pauwels, Noël Bruneel, Jan Tytgat
Laboratory of Toxicology, Campus Gasthuisberg, O&N2, Herestraat 49, P.O. Box 922, B-3000 Leuven, Belgium
• Abstract


DA-p-18 Use of pectin as a drug screen adulterant and its detection by Intect® 7
Raphael C. Wong, Beckie Wong, Olivia Chan, Chan Patel
Branan Medical Corporation
• Abstract


DA-p-19 Drug Screening in Serum Samples with the Dade Behring Viva-E™ System
Gertrud Rochholz, Agnes Heinemann, Cornelia Franzelius
Institut für Rechtsmedizin, Universitätsklinikum Schleswig-Holstein, Germany
• Abstract


DA-p-20 Chemical additives of street heroin in Cairo
Dr. Abd El- Aziz Ghanim , Amal Abd El – Salam El – Bakary and Alaa Ali Hassan
Forensic Medicine and Clinical Toxicology Department, Mansoura University and Medicolegal Administration, Ministry of Justice, Egypt
• Abstract


DA-p-21 Phenacetin is coming back!
Marc Augsburger, Aurélie Bourdon, Frank Sporkert, and Patrice Mangin
Institut Universitaire de Médecine Légale, Rue du Bugnon 21, 1005 Lausanne, Switzerland
• Abstract


DA-p-22 VIAGRA®, CIALIS® and LEVITRA® - the analysis of original and counterfeit tablets used to treat erectile dysfunction
Dariusz Zuba
Institute of Forensic Research, Westerplatte 9, 31033 Krakow, Poland
• Abstract


DA-p-23 LSD, Magic Mushrooms and Peyote in Switzerland
Werner Bernhard, Priska Regenscheit
Institute of Legal Medicine, University of Bern, Buehlstrasse 20, 3012 Bern, Switzerland
• Abstract


Top
TOXINS & HERBALS & VENOMS
TH-p-01 Studies on the cause of an encephalopathy which took place in the limited areas in Japan 2004: a possibility of poisoning by cyanide being contained in a kind of mushroom
Kunio Gonmori1, Kayoko Minakata1, Kanako Watanabe1, Shigeru Sato2, Itaru Toyoshima2, Noriyuki Matsumoto3 and Osamu Suzuki1
1Department of Legal Medicine, Hamamatsu University School of Medicine, Japan; 2Investigative Committee of Acute Encephalopathy in Akita Prefecture, Japan; 3Niigata Prefectural Forest Research Institute, Japan
• Abstract
• Full Text


TH-p-02 UPLC-MS/MS findings in a fatality involving massive ingestion of yew (Taxus spp.) leaves and berries
Carole Jamey1, Nadia Ihadadène2, Françoise Flesch2, Chaouki Mezher3, Esther Szwarc1, Bertrand Ludes1, Antoine Tracqui1
1Laboratoire de Toxicologie, Institut de Médecine Légale, 11 rue Humann, F-67085 Strasbourg, France; 2Centre Antipoison, Hôpitaux Universitaires de Strasbourg, 1 place de l'Hôpital BP 426, F-67091 Strasbourg, France; 3Service de Réanimation, Centre Hospitalier, 2 rue du Docteur-Flamand, F-25200 Montbéliard, France
• Abstract


TH-p-03 Analysis of herbal medicines with risks of abuse
F.S. Romolo1, M.C. Rotolo1, M. Pellegrini2, F. Rosati1
1Legal Medicine Department, Università degli Studi di Roma “La Sapienza”, Viale Regina Elena 336 - 00161 Rome, Italy; 2Clinical Biochemistry Department, Istituto Superiore di Sanità, Viale Regina Elena 299 - 00161 Rome, Italy
• Abstract


TH-p-04 Concentrations of tetrodotoxin and aconitine using a column-switching LC-ESI-MS method in mouse serum
Makiko Hayashida, Makoto Nihira, Youkichi Ohno
Department of Legal Medicine; Nippon Medical School; Bunkyo-Ku, Tokyo 113-8602, Japan
• Abstract


Top
SYMPOSIUM: Medicinal Drugs and Human Performance
MD-01 Drugs and driving – Introduction
Majda Zorec Karlovšek
Institute of Forensic Medicine, Faculty of Medicine, University of Ljubljana, Slovenia
• Abstract


MD-02 Measurement and Interpretation of the Central Effects of Drugs: Implications to Behavioural and Forensic Toxicology
Julia Boyle
School of Biomedical and Molecular Sciences, University of Surrey, Guildford, Surrey, UK
• Presentation


MD-03 Risk of involvement in traffic accidents associated with medicinal drugs
Olaf H. Drummer
Forensic and Scientific Services, Victorian Institute of Forensic Medicine, Department of Forensic Medicine, Monash University, Melbourne, Australia
• Full Text


MD-04 Medicinal drugs and traffic safety - the Norwegian experience
Asbjørg Christophersen
Norwegian Institute of Public Health, Division of Forensic Toxicology and Drug Abuse, Oslo, Norway
• Presentation


MD-05 Medicinal drugs and traffic safety - the Spanish experience
F. Javier Álvarez
Department of Pharmacology, Institute for Alcohol and Drug Studies, Faculty of Medicine, University of Valladolid, Spain
• Full Text


MD-06 Medicinal drugs and traffic safety – European DRUID project
F. Javier Álvarez
Department of Pharmacology, Institute for Alcohol and Drug Studies, Faculty of Medicine, University of Valladolid, Spain
• Full Text


MD-07 The experience with the categorisation of medicinal drugs in Belgium
Alain G. Verstraete
Laboratory of Clinical Biology–Toxicology, Ghent University Hospital, and Department of Clinical Biology, Microbiology and Immunology, Ghent University, Belgium
• Abstract


MD-08 The handling and statistics of Suspected Drugs and Driving Cases in Finland
Sirpa Mykkänen and Pirjo Lillsunde
National Public Health Institute, Laboratory of Alcohol and Substance Abuse, Helsinki, Finland
• Full Text


MD-09 Serving Patient Needs: Marketing Authorization Procedures and Pharmacovigilance
Stanislav Primožič
Ministry of health, Agency of medicinal products and Medicinal devices of the Republic of Slovenia, Ljubljana, Slovenia
• Presentation


MD-10 Evaluation of Medicines Affecting Human Performance
Lovro Stanovnik
Institute of Pharmacology, Medical Faculty , University of Ljubljana, Slovenia
• Full Text


MD-11 Medicinal drug use in Slovenia
Jurij Fürst
Health Assurance Institute of Slovenia (ZZZS), Ljubljana, Slovenia
• Full Text


MD-12 The patern ob benzodiazepines prescribing among Slovenian General Practitioners
Igor Švab, Marko Kolšek, Nena Kopčavar Guček
Department of Family Medicine, Medical School, University of Ljubljana, Ljubljana, Slovenia
• Abstract
• Full Text


MD-13 Ask your Pharmacist
Frankič Darja
Slovenian Chamber of Pharmacy, Ljubljana, Slovenia
• Full Text


MD-14 Drivers attitudes to medicinal drugs and possibilities of preventive activities
Bojan Žlender
Slovenian Road Safety Council, Ljubljana, Slovenia
• Presentation


Top
   




© 2006 Institute of Forensic Medicine, Ljubljana. All rights reserved.